Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients
Clinical trial NCT04155918 · COMPLETED
Trial details
- NCT number
- NCT04155918
- Sponsor
- Arthrosi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2020-09-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.